Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Clinical Trial Coordinator
CONTACT
Early phase team Cambridge Clincial Trials Unit -Cancer Theme
CONTACT
Lead
Cambridge University Hospitals NHS Foundation Trust
With
This is a phase II single arm, open label, prospective trial investigating the efficacy of pembrolizumab plus olaparib in metastatic pancreatic adenocarcinoma patients exhibiting high tumour mutation burden (defined as ≥4 mutations/Mb, including tumours with Mismatch Repair Deficient (MMRD) /Microsatellite Instability (MSI) high).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted